Terry P. Gould, Director, 10% Owner at Corvus Pharmaceuticals, Inc. (CRVS), bought 271,863 shares at $15.00 ($3.0M) on 2016-03-29, disclosed to the SEC on 2016-03-29.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 71,863 | $0 | 0.0% |
| 2 | $15.00 | 40,272 | $604K | 20.1% |
| 3 | $15.00 | 51,712 | $776K | 25.9% |
| 4 | $15.00 | 53,239 | $799K | 26.6% |
| 5 | $15.00 | 54,777 | $822K | 27.4% |
| Total | $11.03 avg | 271,863 |
| $3.0M |
| 100% |
| Filing → |
| CRVS | BUY | 2018-03-13 | $5.6M | — | Filing → |